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GENDER DIFFERENCES IN ARTHRITIS DISABILITY 
ASSOCIATED WITH ANKLE JOINT PAIN: 
A POPULATION-BASED SURVEY 
S Morewitz, J Lira, A Dintcho 
California College of Pediatric Medicine, CA, USA 
Aim: The aim of this study is to determine the extent to which 
there are gender differences in arthritis impairment associated 
with ankle pain. 
Method: A large population-based sample (N=32,440 adults) 
from the 1998 National Health Interview Survey was analyzed 
using multivariate statistical procedures. The Survey elicited self- 
report data on various health and disability problems, including 
ankle joint pain, aching, stiffness or swelling and impairment from 
arthritis in the last 12 months. Chi-square and logistic regression 
were performed to measure possible gender differences in 
arthritis disability associated with ankle joint symptoms. 
Results: Chi-Square statistical analysis showed that women 
(56%) were more likely to have arthritis impairment associated 
with ankle symptoms in the last 12 months (Chi-Square=32.66, 
df=l, p<0.000) than men (45%) (Chi-Square=14.12, df=l, 
p<0.000). Logistic regression showed that this relationship 
remained significant after adjusting for confounding factors. 
Conclusions: Women are more likely than men to suffer arthritis 
disability associated with ankle joint pain, aching, stiffness, or 
swelling. However, a majority of both women and men suffer from 
significant arthritis disability related to their ankle symptoms. 
Future research should analyze the extent to which gender 
differences lead to women's increased risks of developing 
lower extremity complications due to altered foot and ankle 
biomechanics, pressure, and trauma. 
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EFFECTS OF TUMOR NECROSIS FACTOR-co ON 
PROLIFERATION AND RNA EXPRESSION OF HUMAN 
OSTEOARTHRITIC SYNOVIOCYTES 
Wenxuan Cao, Ming Li, Zhanghong Liu 
Department of Pharmacology, 77anjin Bailou Hospital 77anjin, 
China 
Aim: To investigate the effect of tumor necrosis factor-& (TNF-&) 
on proliferation and RNA expression of human osteoarthritic syn- 
oviocytes, and for this effect, regulation of anti-inflammatory 
drugs and cytokins. 
Methods: Human synoviocytes were isolated from tissues 
obtained from the hip and knee joints of osteoarthritis (OA) under- 
going arthoplasty and cultured. Proliferation of synoviocytes 
were determined using M-I-I" colorimetric and radioautographic 
methods, respectively. Their RNA expression was determined by 
[3H]-uridine incorporation. 
Results: At concentration from 5 X 104 to 5 X 106 U/litre-1, TNF- 
c~ stimulated proliferation a d enhanced synthesis of RNA 
metabolism of OA synoviocytes. At 5 X 106 U/litre-1, after 24h 
incubation with OA synoviocytes, the proliferative rate of synovial 
fibroblast cell increased 37.8%, and incorporation of [3H]-uridine 
by synoviocytes reached maximum: 1.79 X 10-8%, (Zg/day -1 ). 
After the synoviocytes were incubated with various concentration 
of indomethacin (INDO), dexamethasone (DEX), EGF, IL-6 and 
IFN-a, respectively, DEX and IFN-& could antagonize INF-c~- 
induced proliferation of synoviocytes only when their drugs were 
used at levels above their therapeutic concentration. 
Conclusion: TNF-c~ can induce proliferation a d RNA expression 
of OA synoviocytes. Ant-inflammatory drugs and cytokines do 
not significantly antagonize this effect. 
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DETERMINATION OF CONCENTRATIONS OF HYALURONAN 
AND AGGRECAN AND MOLECULAR WEIGHT OF 
HYALURONAN REQUIRED FOR MAINTENANCE OF THE 
ELASTICITY OF JOINT FLUID AND CRTILAGE MATRIX 
Y Kato, T Hamada, M Nishimna 
Departments of Biochemistry and Prosthetic Dentistry, Faculty of 
Dentistry, Hiroshima University, Japan 
To determine concentrations and sizes of hyaluronan and 
aggrecan-hyaluronan complex required for the elasticity of joint 
fluid and cartilage matrix, the elasticity (G') of hyaluronan and 
aggrecan-hyaluronan complex was determined by a cone-plate 
viscometer under near static (0.1 Hz) and dynamic (1-10 Hz) con- 
ditions. The elasticity of 2000kDa hyaluronan solution at 4 mg/ml 
was >20-fold higher in dynamic conditions than in static condi- 
tions. Under the dynamic conditions, the decrease in the hyaluro- 
nan concentration (<2 mg/ml) or the hyaluronan size (800kDa) 
abolished the elasticity of the hyaluronan solution. The elasticity 
of hyaluronan solution (4 mg/ml) was similar to that of hyaluronan 
(0.5 mg/ml)-aggrecan (50 mg/ml) solution, emphasizing the 
importance of the elasticity of joint fluid during movement. 
Aggrecan alone had viscosity but not elasticiticy. However, 
hyaluronan at 0.001-0.1 mg/ml markedly increased the elasticity 
of 50 mg/ml aggrecan solution concentration-dependently; the 
elasticity of aggrecan-hyaluronan complex reached a plateau at a 
500:1 (w/w) ratio. Hyaluronan selectively increased the elasticity 
but not viscosity of aggrecan solutions. Aggrecan at low concen- 
trations (<20 mg/ml) or small hyaluronan (800kDa) did not pro- 
duce the elasticity even in the presence of large hyaluronan or 
aggrecan at high concentrations (50 mg/ml), resepectively. 
Intraarticular injections of large hyaluronan may have beneficial 
effect on OA patients partly via the increase in the elasticity of 
joint fluid and damaged cartilage. 
